PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 58 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $114,000 | -94.4% | 86,000 | -89.1% | 0.00% | – |
| Q4 2021 | $2,054,000 | +186.1% | 786,400 | +240.6% | 0.00% | – |
| Q3 2021 | $718,000 | +187.2% | 230,859 | +243.1% | 0.00% | – |
| Q2 2021 | $250,000 | -53.8% | 67,284 | -56.9% | 0.00% | – |
| Q1 2021 | $541,000 | -1.3% | 156,285 | -4.1% | 0.00% | – |
| Q4 2020 | $548,000 | +426.9% | 162,978 | +449.6% | 0.00% | – |
| Q3 2020 | $104,000 | -8.0% | 29,653 | +20.9% | 0.00% | – |
| Q2 2020 | $113,000 | -72.2% | 24,529 | -42.7% | 0.00% | – |
| Q1 2019 | $407,000 | – | 42,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,607,044 | $4,194,000 | 0.48% |
| NEA Management Company, LLC | 6,643,704 | $17,340,000 | 0.35% |
| Platform Technology Partners | 251,723 | $657,000 | 0.29% |
| DAFNA Capital Management LLC | 378,611 | $988,000 | 0.25% |
| Avidity Partners Management LP | 4,405,000 | $11,497,000 | 0.24% |
| Endurant Capital Management LP | 360,078 | $940,000 | 0.23% |
| Rock Springs Capital Management LP | 2,581,299 | $6,737,000 | 0.16% |
| RA Capital Management | 2,850,000 | $7,439,000 | 0.13% |
| New Legacy Group, LLC | 240,575 | $628,000 | 0.12% |
| XTX Topco Ltd | 15,574 | $41,000 | 0.02% |